Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
GEVA > SEC Filings for GEVA > Form 8-K on 9-Dec-2013All Recent SEC Filings

Show all filings for SYNAGEVA BIOPHARMA CORP



Entry into a Material Definitive Agreement

Item 1.01 Entry into a Material Definitive Agreement.

Amended and Restated License Agreement

On December 3, 2013, Synageva BioPharma Corp. ("Synageva") entered into a second amended and restated license agreement ("Second A&R License Agreement") with the University of Georgia Research Foundation, Inc. ("UGARF"). The Second A&R License Agreement amends, restates and clarifies certain provisions, rights and obligations under the original amended and restated license agreement, dated as of April 5, 2007, between Synageva and UGARF.

Synageva's rights under the Second A&R License Agreement include an exclusive, worldwide, sublicensable license to UGARF's patent rights to develop, make, use and commercialize products derived from protein expression platform technology. UGARF is eligible to receive a low single digit royalty on net sales of products on a country-by-country basis until the last to expire of the licensed patents in such country. UGARF can terminate the license or, at UGARF's discretion, convert the license into a non-exclusive license, if Synageva materially breaches the agreement, makes any materially false reports to UGARF, or fails to pay any required consideration under the agreement. Synageva has the right to terminate the agreement upon 60 days' prior written notice to UGARF.

  Add GEVA to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for GEVA - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.